LA JOLLA, Calif., Dec. 16, 2013 (GLOBE NEWSWIRE) -- EHouse Global, Inc. (OTCBB: EHOS ), (the "Company") ( www.EHouse-Global.com ) would like to announce a new article was posted to www.ScienceDaily.com on October 21, 2013, which unveils a recent study published by The Journal of Pediatrics ( http://www.jpeds.com ) that extensively explores the link between low levels of vitamin D and anemia in children.
Researchers studied blood samples from more than 10,400 children to track their levels of vitamin D and hemoglobin. Researchers found that Vitamin D levels were consistently lower in children with low hemoglobin levels compared with their non-anemic counterparts.
The sharpest spike in anemia risk occurred with mild vitamin D deficiency, defined as vitamin D levels below 30 nanograms per milliliter (ng/ml). Children with levels below 30 ng/ml had nearly twice the anemia risk of those with normal vitamin D levels. Severe vitamin D deficiency is defined as vitamin D levels at or below 20 ng/ml. Both mild and severe deficiency requires treatment with nutritional supplements.
The investigators say several mechanisms could account for the link between vitamin D and anemia, including vitamin D's effect on red blood cell production in the bone marrow, as well as its ability to regulate immune inflammation, a known catalyst of anemia.
Ehouse Global's nutritional supplement company, NutraLiquids LLC ( www.NutraLiquids.com ), has created a complete line of great tasting liquid supplements. The Company's KidsDaily™ product contains 400 IU of vitamin D per serving (100% of the recommended daily intake), is kid-friendly-flavored in Orange-Mango-Pineapple-Banana , and comes in a fun daily pouch. The company also carries a standalone Liquid vitamin D 3 supplement for adults, which contains 5,000 IU of vitamin D.
Scott Corlett, CEO of Ehouse Global, Commented:
"With the large number of children affected by diseases that could be prevented with nutrition, we decided to create a liquid multi-vitamin for kids. With four children of my own, I understand the value of supplementation and the importance of a product that not only keeps my children healthy, but tastes great too.
"What really differentiates us within this particular opportunity is our individual packaged daily portions which make if fun for the children and convenient for their parents."
About EHouse Global (EHOS)
EHouse Global is a publicly traded company on the OTCBB Market stock exchange under the ticker symbol EHOS. Headquartered in La Jolla, CA, EHouse Global acquires, develops and sells leading edge consumer oriented products ready for rapid commercialization. Much of its resources are dedicated to research and development in order to provide consumers with quality options while meeting the expectations of its investors. For information about EHouse go to www.ehouse-global.com
Through our wholly owned subsidiary NutraLiquids LLC, our launch includes 16 different liquid nutritional products in single serving pouches with some products also available in 30 day supply, 30 ounce bottles. Each product is loaded with vitamins, nutrients and natural ingredients proven to support each product's unique claim.
From Immunity Support to Weight loss, Omega 3 Heart Health, Detox, Energy, Sleep, Joint Support, Bone Health, Daily Vitamins and even Hangover prevention, we have created a wide variety of hot product segments for the large and growing nutrition industry and are poised for significant growth.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the ability of the Company to reach its expansion goals and generate exciting new developments. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov .
IR Contact:
